Insmed

Youtube Subscribe

Open: 20.51 Close: 21.1 Change: 0.59

Is Insmed a good investment? This what an AI found.

The game is changing. There is a new strategy to evaluate Insmed fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Insmed are: Insmed, stock, year, low, high, expect, reach, and the …

Concept Map

Semantic Network

Stock Summary

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease. It is also developing Brensocatib.

Today's Summary

Insmed (NASDAQ:INSM) shareholders have endured a 31% loss from investing in the stock three years ago. Analysts expect Insmed Incorporated stock to reach the higher price of $52.00, while the lowest price estimate is $28.00.

Today's News

Insmed stock opened at $20.32 on Friday. Insmed has a one year low of $16.04 and a one-year high of $28.94. The company last released its earnings results on May 4th. Insmed (NASDAQ:INSM) shareholders have endured a 31% loss from investing in the stock three years ago. Insmed has 4 warning signs (and 1 which sits too well with us) we think you should know. Analysts expect Insmed Incorporated stock to reach the higher price of $52.00, while the lowest price estimate is $28.00. The revenue for Treprostinil Palmitil is expected to reach an annual total of $326 mn by 2036. The Director, IT Global Business Applications is responsible for end-to-end solution design, implementation and support of Insmeds global applications portfolio. Provides oversight and guidance to the team to ensure the Insmed Financial Cycle/LE process is followed.

Stock Profile

"Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey."

Keywords

How much time have you spent trying to decide whether investing in Insmed? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Insmed are: Insmed, stock, year, low, high, expect, reach, and the most common words in the summary are: stock, common, inc, sedol, com, insmed, pharmaceutical, . One of the sentences in the summary was: Analysts expect Insmed Incorporated stock to reach the higher price of $52.00, while the lowest price estimate is $28.00.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #stock #common #inc #sedol #com #insmed #pharmaceutical.

Read more →

Youtube Subscribe

---